| RS587777493 |
HCN1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 24 |
| RS587777494 |
HCN1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 24 |
| RS587777495 |
HCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 24 |
| RS587777496 |
GJC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 2, Spastic paraplegia |
| RS587777498 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia |
| RS587777499 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia |
| RS587777500 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia 29 |
| RS587777501 |
CCNO
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia |
| RS587777502 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia |
| RS587777503 |
CCNO
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 29, Primary ciliary dyskinesia |
| RS587777504 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS587777505 |
TBC1D32
|
Health Risk |
Likely pathogenic |
Alsahan-Harris syndrome, Orofaciodigital syndrome IX |
| RS587777506 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS587777507 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS587777508 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS587777509 |
DNMT3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Inborn genetic diseases |
| RS587777510 |
DNMT3A
|
Health Risk |
Pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS587777511 |
MAB21L2
|
Health Risk |
Likely pathogenic |
Colobomatous microphthalmia-rhizomelic dysplasia syndrome, Colobomatous microphthalmia-rhizomelic dysplasia syndrome |
| RS587777512 |
MAB21L2
|
Health Risk |
Pathogenic |
Colobomatous microphthalmia-rhizomelic dysplasia syndrome, Colobomatous microphthalmia-rhizomelic dysplasia syndrome |
| RS587777513 |
MAB21L2
|
Health Risk |
Likely pathogenic |
Colobomatous microphthalmia-rhizomelic dysplasia syndrome, Colobomatous microphthalmia-rhizomelic dysplasia syndrome |
| RS587777514 |
MAB21L2
|
Health Risk |
Conflicting classifications of pathogenicity |
Colobomatous microphthalmia-rhizomelic dysplasia syndrome, Colobomatous microphthalmia-rhizomelic dysplasia syndrome |
| RS587777515 |
MMP20
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A2, Amelogenesis imperfecta hypomaturation type 2A2 |
| RS587777516 |
MMP20
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A2, Amelogenesis imperfecta hypomaturation type 2A2 |
| RS587777517 |
ANGPTL4
|
Health Risk |
association |
Plasma triglyceride level quantitative trait locus, Plasma triglyceride level quantitative trait locus |
| RS587777518 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, progressive familial intrahepatic |
| RS587777519 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS587777520 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS587777521 |
TJP2
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS587777522 |
ADNP
|
Health Risk |
Pathogenic/Likely pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, Intellectual disability |
| RS587777523 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, Inborn genetic diseases |
| RS587777524 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS587777525 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS587777526 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, Inborn genetic diseases |
| RS587777527 |
RPL21
|
Health Risk |
Pathogenic |
Hypotrichosis 12, Hypotrichosis 12 |
| RS587777528 |
ORAI1
|
Health Risk |
Pathogenic |
Myopathy, tubular aggregate |
| RS587777529 |
RASGRP2
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 18, Platelet-type bleeding disorder 18 |
| RS587777530 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS587777531 |
FAM20A
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS587777532 |
CTSC
|
Health Risk |
Pathogenic |
Papillon-Lefèvre syndrome, Papillon-Lefèvre syndrome |
| RS587777533 |
CTSC
|
Health Risk |
Pathogenic |
Papillon-Lefèvre syndrome, Periodontitis |
| RS587777534 |
CTSC
|
Health Risk |
Pathogenic/Likely pathogenic |
Periodontitis, aggressive 1 |
| RS587777535 |
SLC24A4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A5, Amelogenesis imperfecta hypomaturation type 2A5 |
| RS587777536 |
SLC24A4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A5, Amelogenesis imperfecta hypomaturation type 2A5 |
| RS587777537 |
SLC24A4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A5, Amelogenesis imperfecta hypomaturation type 2A5 |
| RS587777538 |
KPNA7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS587777540 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
CBL-related disorder, Intellectual disability |
| RS587777542 |
AP1S2
|
Health Risk |
Pathogenic |
Pettigrew syndrome, Pettigrew syndrome |
| RS587777543 |
PIGQ
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 77 |
| RS587777545 |
KRT71
|
Health Risk |
Pathogenic |
Hypotrichosis 13, Hypotrichosis 13 |
| RS587777546 |
IFT27
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 19, IFT27-related disorder |
| RS587777547 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS587777548 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS587777549 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS587777550 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS587777551 |
TTC7A
|
Health Risk |
Pathogenic |
Gastrointestinal defects and immunodeficiency syndrome 1, Gastrointestinal defects and immunodeficiency syndrome 1 |
| RS587777552 |
ARHGDIA
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 8 |
| RS587777553 |
ARHGDIA
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 8 |
| RS587777557 |
SCN3B
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777558 |
SCN3B
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777559 |
SCN4B
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777560 |
SCN4B
|
Health Risk |
Pathogenic |
Atrial fibrillation, familial |
| RS587777561 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy 1 without immunodeficiency |
| RS587777562 |
PGM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 23, Inborn genetic diseases |
| RS587777564 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS587777565 |
PGM3
|
Health Risk |
Pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS587777566 |
VEGFC
|
Health Risk |
Pathogenic |
Lymphatic malformation 4, Lymphatic malformation 4 |
| RS587777567 |
VEGFC
|
Health Risk |
Pathogenic |
Lymphatic malformation 4, Lymphatic malformation 4 |
| RS587777568 |
RPS29
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 13, Diamond-Blackfan anemia 13 |
| RS587777569 |
RPS29
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 13, Diamond-Blackfan anemia 13 |
| RS587777570 |
KIF5C
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 2, Complex cortical dysplasia with other brain malformations 2 |
| RS587777572 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS587777573 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS587777574 |
CHCHD10
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, Autosomal dominant mitochondrial myopathy with exercise intolerance |
| RS587777575 |
IFIH1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 7, Aicardi-Goutieres syndrome 7 |
| RS587777576 |
IFIH1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 7, Aicardi-Goutieres syndrome 7 |
| RS587777577 |
SLC13A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS587777578 |
SLC13A5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 25 |
| RS587777579 |
FGF5
|
Health Risk |
Pathogenic |
Trichomegaly, Trichomegaly |
| RS587777580 |
FGF5
|
Health Risk |
Pathogenic |
Trichomegaly, Trichomegaly |
| RS587777581 |
FGF5
|
Health Risk |
Pathogenic |
Trichomegaly, Trichomegaly |
| RS587777583 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS587777584 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS587777585 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Inborn genetic diseases |
| RS587777586 |
RAF1
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1NN, Dilated cardiomyopathy 1NN |
| RS587777587 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1NN, Primary dilated cardiomyopathy |
| RS587777589 |
AARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 8, Pulmonary hypoplasia |
| RS587777590 |
AARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy, progressive |
| RS587777591 |
AARS2
|
Health Risk |
Pathogenic |
Leukoencephalopathy, progressive |
| RS587777593 |
TARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 21, Combined oxidative phosphorylation defect type 21 |
| RS587777594 |
TARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 21, Combined oxidative phosphorylation defect type 21 |
| RS587777595 |
NPR2
|
Health Risk |
Pathogenic |
Tall stature-scoliosis-macrodactyly of the great toes syndrome, Tall stature-scoliosis-macrodactyly of the great toes syndrome |
| RS587777596 |
NPR2
|
Health Risk |
Pathogenic |
Tall stature-scoliosis-macrodactyly of the great toes syndrome, Tall stature-scoliosis-macrodactyly of the great toes syndrome |
| RS587777597 |
NPR2
|
Health Risk |
Pathogenic |
Tall stature-scoliosis-macrodactyly of the great toes syndrome, Tall stature-scoliosis-macrodactyly of the great toes syndrome |
| RS587777598 |
ELOVL4
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 34, Stargardt disease 3 |
| RS587777599 |
PRPF4
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 70, Retinal dystrophy |
| RS587777600 |
FDX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn mitochondrial myopathy, Mitochondrial myopathy |
| RS587777601 |
CRYBB3
|
Health Risk |
Pathogenic |
Cataract 22 multiple types, Cataract 22 multiple types |
| RS587777602 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS587777603 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS587777604 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
PHARC syndrome, Cone dystrophy |